ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Realites

Realites (ALREA)

1.30
0.02
( 1.56% )
Actualizado: 09:07:43

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
1.30
Postura de Compra
1.24
Postura de Venta
1.335
Volume Operado de la Acción
19,578
1.29 Rango del Día 1.68
1.00 Rango de 52 semanas 17.85
Capitalización de Mercado [m]
Precio Anterior
1.28
Precio de Apertura
1.35
Última hora de negociación
09:07:22
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
2,604
Acciones en circulación
4,789,993
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
2.27
Beneficio por acción (BPA)
0.57
turnover
403.42M
Beneficio neto
2.74M

Acerca de Realites

Sector
Real Estate Investment Trust
Industria
Real Estate Investment Trust
Sede
Saint-herblain, Loire-atlantique, Fra
Fundado
-
Realites is listed in the Real Estate Investment Trust sector of the Euronext with ticker ALREA. The last closing price for Realites was 1.28 €. Over the last year, Realites shares have traded in a share price range of 1.00 € to 17.85 €.

Realites currently has 4,789,993 shares in issue. The market capitalisation of Realites is 6.13 € million. Realites has a price to earnings ratio (PE ratio) of 2.27.

ALREA Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.3-18.751.61.68139501.36652944DE
4-0.535-29.15531335151.8351.965137131.62249755DE
12-0.69-34.67336683421.992.05126041.6917429DE
26-4.52-77.66323024055.827.24145772.71968094DE
52-16.55-92.717086834717.8517.85132825.04626511DE
156-32.2-96.119402985133.5421208817.57363265DE
260-23.2-94.69387755124.5421234520.78748949DE

ALREA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Realites?
El precio actual de las acciones de Realites es 1.30 €
¿Cuántas acciones de Realites están en circulación?
Realites tiene 4,789,993 acciones en circulación
¿Cuál es la capitalización de mercado de Realites?
La capitalización de mercado de Realites es EUR 6.13M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Realites?
Realites ha negociado en un rango de 1.00 € a 17.85 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Realites?
El ratio precio/beneficio de Realites es 2.27
¿Cuál es el ratio de efectivo a ventas de Realites?
El ratio de efectivo a ventas de Realites es 0.02
¿Cuál es la moneda de reporte de Realites?
Realites presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Realites?
El último ingresos anual de Realites es EUR 403.42M
¿Cuál es el último beneficio anual de Realites?
El último beneficio anual de Realites es EUR 2.74M
¿Cuál es la dirección registrada de Realites?
La dirección registrada de Realites es 1 IMPASSE CLAUDE NOUGARO, SAINT-HERBLAIN, LOIRE-ATLANTIQUE, 44800
¿Cuál es la dirección del sitio web de Realites?
La dirección del sitio web de Realites es www.groupe-realites.com
¿En qué sector industrial opera Realites?
Realites opera en el sector REAL ESTATE INVESTMENT TRUST

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALCABCabasse SA
0.88 €
(91.30%)
69.93k
VTRVitura
5.10 €
(43.26%)
1.27k
DMSBSDiagnostic Medical Systems
0.007 €
(40.00%)
15.1k
ALVERVergnet
0.0009 €
(28.57%)
21.74M
MLNMAMiguet Et Associes
0.10 €
(19.05%)
3.32k
TUVDSBio UV Group DS
0.0026 €
(-88.74%)
719.5k
ALCYBCybergun
0.0001 €
(-50.00%)
17.59M
BAIOdyssey Acquisition SA
0.143 €
(-44.14%)
503.31k
ALBOOBOOSTHEAT
0.0228 €
(-17.99%)
79.12k
MLWEYWeya
0.0225 €
(-16.67%)
29.31k
ATOAtos SE
0.0021 €
(0.00%)
923.08M
BCPBanco Comercial Portugues SA
0.5036 €
(-0.59%)
28.92M
ALVERVergnet
0.0009 €
(28.57%)
21.74M
ALCYBCybergun
0.0001 €
(-50.00%)
17.59M
ALNRGEnergisme SA
0.004 €
(8.11%)
9.57M
i_like_bb_stock i_like_bb_stock 4 minutos hace
EFSH took a few here looks ready
EFSH
mikepgator mikepgator 4 minutos hace
The primary focus of this trial is safety, and getting the data required by the FDA to resubmit the IDE application. All this talk from SC8 is nonsense.


Public Title of Study:
Testing the Safety of a gel-based radiotherapy treatment for cancer that has spread into the l
RDGL
naveedkhan naveedkhan 4 minutos hace
Please do keep us all posted on ur trades. Fascinating!
FNMA
Spartanfan1 Spartanfan1 4 minutos hace
This started off as a revival… it’s changed into a viable business in an industry in need of more treatment centers… and the future of this company looks very very bright

If this company does it right… it might become more of a national presence and see a pps that could reach $’s. Th
ADIA
1jas 1jas 4 minutos hace
yesterday started out the same way. ?
AFFU
prototype_101 prototype_101 4 minutos hace
LWLG won the Optical Integration award at ECOC for what? the OFC 200gb Modulator with World record performance metrics? Yes, but also more likely for the overall work LWLG has been doing to successfully Integrate their Polymers onto Silicon Photonics

We never got the PECC presentation
LWLG
dinogreeves dinogreeves 4 minutos hace
Yes, the tape will tell the story.
SMCI
RickNagra RickNagra 4 minutos hace
Low volume takedown.  We will close in the green as per my pet monkey Banana.  He is quite smart.  He has his own terminal complete with level 2 quotes.
FNMA
dexprs dexprs 4 minutos hace
Sold FLUT at 268.1 for a hefty gain.
Added: SERV and UTI. Not the infection, lol.
FLUT SERV
Debunkinator Debunkinator 4 minutos hace
4's, when you leave turn out the lights. TIA $$$$$ Weeeeeeeeeeeeeeeeeee
ASII
boi568 boi568 5 minutos hace
The researchers who are working on drug development in Biogen, Lilly, etc. are not experts in Alzheimer's Disease; they are experts in designing and creating monoclonal antibodies against a specified target. These companies would therefore have more of a chance of developing anti-cancer drugs than S
AVXL
BottomBounce BottomBounce 5 minutos hace
Plug Launches Industry's First Spot Pricing for Green Hydrogen
https://finance.yahoo.com/news/plug-launches-industrys-first-spot-120000604.html $CEG $PLUG $BLDP
CEG PLUG
The Great Pumpkin The Great Pumpkin 5 minutos hace
Lebby lied and is no longer with the company. You need a reality check and to refresh your copy and pastes. None of Lebby's statements are credible or valid.

#scam
LWLG
81vette 81vette 5 minutos hace
Insane buying ratio https://ih.advfn.com/stock-market/NASDAQ/meihua-international-med-MHUA/trades
MHUA
Mugsy Mugsy 5 minutos hace
I've seen the video and will share the link. It's got excellent information. I don't think it was well circulated though. 

https://youtu.be/kpZ5j8riSxQ

UMAV
Invest-in-America Invest-in-America 5 minutos hace
CDT: See its 'CHART' right now, below, Quantum-AI-Medical-Healthcare-Everything , PEEPS!!

https://media1.giphy.com/media/v1.Y2lkPTc5MGI3NjExYXdnaTc4amtzNms0aDBzbzRteHhzZXFtdTY4dnM0ZGp6cThja2tqZiZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/S462DTPLA2KVN0fIeF/giphy.gif
rogers711 rogers711 5 minutos hace
This volume we aren't coming anywhere near it, this is disgusting... 
RDGL
BottomBounce BottomBounce 5 minutos hace
Plug Launches Industry's First Spot Pricing for Green Hydrogen
https://finance.yahoo.com/news/plug-launches-industrys-first-spot-120000604.html $PLUG
PLUG
Budots Budots 5 minutos hace
$STEK Stemtech- $600 million in sales, has merged with Seacret Viago, $2 billion in sales #Stemcells https://www.youtube.com/watch?v=H_qUxQOIPjs
STEK
conix conix 5 minutos hace
Chart

www.stockscores.com/chart.asp?TickerSymbol=dats&TimeRange=90&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=830&ChartHeight=500&LogScale=None&Band=BB&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=100&Indicator1=MACD&Indicator2=MACD&Indicator3=FStoch&Indicator4
blackhawks blackhawks 5 minutos hace
We're going to need a 'critical mass' of Trump overreach and flat out law breaking sufficient to bring Roberts and Justice Handmaid's Tale to the point of forehead slaps that can be heard down the hallway sufficient to aggravate Brett's beer induced hangover headache, make Alito drop his flag catalo
ls7550 ls7550 5 minutos hace
Once/year AIM reviews applied separately to Dow and gold (real inflation adjusted) prices), is indicating to start 2025 with 50/30/20 stock/cash/gold. Personally I prefer the midcap (S&P400) as the stock choice as that is less prone to periodically being accelerated and then subsequently dragged by
Maxthedog Maxthedog 5 minutos hace
The trend is your friend, wait till earnings if your a buyer 45 cents is what I’m saying, I don’t want it to happen but many other stocks after their fallen after giving good earnings and revenues. Then all the buyers that bought will be negative unless they bought into the .03-.15
ELTP
dinogreeves dinogreeves 5 minutos hace
AMZN going to spend 105 billion on AI.
AMZN
Babubd Babubd 6 minutos hace
EPIC MOVE COMING 🚀🚀🚀🚀🚀🚀!!

AABB will be Dollars this year..IMO!!
AABB

Su Consulta Reciente

Delayed Upgrade Clock